Abstract: To provide: (1) a modified release liquid (suspension) containing mirabegron, (2) a ready-to-suspend pharmaceutical composition containing mirabegron, and (3) a mirabegron-containing pharmaceutical composition that does not generate undissolved lumps, even when it is suspended at the time of use. The present invention relates to a pharmaceutical composition containing a complex of mirabegron or a pharmaceutically acceptable salt thereof with sodium polystyrene sulfonate.

Abstract: To provide: (1) a modified release liquid (suspension) containing mirabegron, (2) a ready-to-suspend pharmaceutical composition containing mirabegron, and (3) a mirabegron-containing pharmaceutical composition that does not generate undissolved lumps, even when it is suspended at the time of use. The present invention relates to a pharmaceutical composition containing a complex of mirabegron or a pharmaceutically acceptable salt thereof with sodium polystyrene sulfonate.

Abstract: An order assembly production method comprising preparing manufacturing schedules of several months on the basis of a demand forecast on a predetermined period basis that is shorter than a monthly basis, reviewing the manufacturing schedules every predetermined period, and issuing the reviewed manufacturing schedules of several months, issuing a procurement instruction of parts on the basis of the reviewed manufacturing schedules, issuing a manufacture instruction when an order is received from a customer, and assembling the parts in accordance with the manufacture instruction.

Abstract: An order assembly production system and method comprises a vender managed inventory (VMI) system and a forecast presented to a component vender. A prospect production is performed until intermediate products are obtained, the intermediate products are stocked, and final assembly is performed after an order is accepted. The final assembly is performed from the intermediate product, resulting in a shorter lead time and preventing the loss of sales opportunities due to shortages. Since no final product is stocked, excess production is avoided. In addition, because the intermediate products may be designed to be general-purpose and may be used in a plurality of products, demand fluctuations for the intermediate products can be buffered.